Skip to Content
Merck
All Photos(1)

Key Documents

HPA027543

Sigma-Aldrich

Anti-PTAFR antibody produced in rabbit

Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution

Synonym(s):

Anti-platelet-activating factor receptor

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
Human Protein Atlas Number:
NACRES:
NA.41

biological source

rabbit

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

product line

Prestige Antibodies® Powered by Atlas Antibodies

form

buffered aqueous glycerol solution

species reactivity

human

technique(s)

immunohistochemistry: 1:200- 1:500

immunogen sequence

LDSTNTVPDSAGSGNVTRCFEHYEKGS

UniProt accession no.

shipped in

wet ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... PTAFR(5724)

General description

Platelet-activating factor receptor (PTAFR) gene is mapped to human chromosome 1p35.3. PTAFR has seven transmembrane and is expressed in leukocytes, endothelial cells and platelets on the plasma and nuclear membranes. Among the two isoforms, isoform 1 is regulated by inflammation process (Location). Isoform 2 is majorly present in kidney, lungs, spleen and heart.

Immunogen

platelet-activating factor receptor recombinant protein epitope signature tag (PrEST)

Biochem/physiol Actions

Platelet-activating factor receptor (PTAFR) is highly expressed on the airway epithelial cells exposed to cigarette smoke. It also interacts with phosphorylcholine in the microbial cell wall and facilitates its entry in chronic obstructive pulmonary disease (COPD). It contributes to the progression of atherosclerosis and polymorphisms in the PTAFR may increase a risk of developing coronary heart disease. It also participates in the inflammation events associated with asthma and may serve as a potential therapeutic target for treating invasive pneumococcal disease.

Features and Benefits

Prestige Antibodies® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:
  • IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
  • Protein array of 364 human recombinant protein fragments.

Linkage

Corresponding Antigen APREST77933

Physical form

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide.

Legal Information

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

G-protein-independent activation of Tyk2 by the platelet-activating factor receptor
Lukashova V, et al.
Test, 276(26), 24113-24121 (2001)
Airway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary disease
Shukla SD, et al.
International Journal of Chronic Obstructive Pulmonary Disease, 9(12), 853-853 (2014)
Association of platelet-activating factor receptor gene rs5938 (G/T) and rs313152 (T/C) polymorphisms with coronary heart disease and blood stasis syndrome in a Chinese Han population
Zheng GH, et al.
Chinese Journal of Integrative Medicine, 23(12), 893-900 (2017)
Signalling or binding: the role of the platelet-activating factor receptor in invasive pneumococcal disease
Iovino F, et al.
Cellular Microbiology, 15(6), 870-881 (2013)
Pharmacogenomics of multigenic diseases: sex-specific differences in disease and treatment outcome.
Pinsonneault J and Wolfgang S
AAPS PharmSci, 5(4), 49-61 (2003)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service